Glanbia Stock Price, News & Analysis (OTCMKTS:GLAPY)

$84.30 0.00 (0.00 %)
(As of 01/18/2018 12:07 PM ET)
Previous Close$84.30
Today's RangeN/A
52-Week Range$84.30 - $101.75
Average Volume17 shs
Market Capitalization$4.99 billion
P/E RatioN/A
Dividend Yield0.87%

About Glanbia (OTCMKTS:GLAPY)

Glanbia logoGlanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The Company's Glanbia Nutritionals segment provides nutritional solutions. It manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.

Receive GLAPY News and Ratings via Email

Sign-up to receive the latest news and ratings for GLAPY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
SectorConsumer Staples


Debt-to-Equity RatioN/A
Current Ratio1.80%
Quick Ratio1.27%


Trailing P/E RatioN/A
Forward P/E Ratio16.83
P/E Growth2.42

Sales & Book Value

Annual Sales$3.15 billion
Price / Sales1.58
Cash Flow$6.58 per share
Price / Cash12.81
Book Value$22.93 per share
Price / Book3.68


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares59,210,000

Glanbia (OTCMKTS:GLAPY) Frequently Asked Questions

What is Glanbia's stock symbol?

Glanbia trades on the OTCMKTS under the ticker symbol "GLAPY."

When will Glanbia make its next earnings announcement?

Glanbia is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for Glanbia.

Who are some of Glanbia's key competitors?

Who are Glanbia's key executives?

Glanbia's management team includes the folowing people:

  • Mark A. Garvey, Group Finance Director, Executive Director (Age 52)
  • Hugh McGuire, CEO - Glanbia Performance Nutrition, Executive Director (Age 46)
  • Brian Phelan, Chief Executive Officer - Glanbia Nutritionals, Executive Director (Age 50)
  • Siobhan Talbot, Group Managing Director, Executive Director (Age 53)
  • Michael Patten, Group Human Resources & Corporate Affairs Director (Age 54)
  • Tom Tench, Group Corporate Development Director (Age 46)
  • Michael Horan, Group Company Secretary (Age 52)
  • Henry V. Corbally, Group Non-Executive Chairman of the Board (Age 62)
  • Martin Keane, Non-Executive Vice Chairman of the Board (Age 61)
  • Patrick Murphy, Non-Executive Vice Chairman of the Board (Age 58)

How do I buy Glanbia stock?

Shares of Glanbia can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Glanbia's stock price today?

One share of Glanbia stock can currently be purchased for approximately $84.30.

How big of a company is Glanbia?

Glanbia has a market capitalization of $4.99 billion and generates $3.15 billion in revenue each year. Glanbia employs 6,211 workers across the globe.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House, KILKENNY,, Ireland. The company can be reached via phone at +353-56-7772200 or via email at [email protected]

MarketBeat Community Rating for Glanbia (GLAPY)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  58 (Vote Underperform)
Total Votes:  100
MarketBeat's community ratings are surveys of what our community members think about Glanbia and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Glanbia (OTCMKTS:GLAPY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AHoldHold
Consensus Rating Score: N/AN/A2.002.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Glanbia (OTCMKTS:GLAPY) Consensus Price Target History

Price Target History for Glanbia (OTCMKTS:GLAPY)

Glanbia (OTCMKTS:GLAPY) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
10/25/2016InvestecUpgradeSell -> HoldView Rating Details
(Data available from 1/18/2016 forward)


Earnings History for Glanbia (OTCMKTS:GLAPY)

No earnings announcements for this company have been tracked by


Glanbia (OTCMKTS:GLAPY) Earnings Estimates

Current Year EPS Consensus Estimate: $5.01 EPS
Next Year EPS Consensus Estimate: $5.27 EPS


Dividend History for Glanbia (OTCMKTS:GLAPY)

No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Glanbia (OTCMKTS GLAPY)

No insider trades for this company have been tracked by


Glanbia (OTCMKTS GLAPY) News Headlines

Glanbia (GLAPY) Cut to Hold at Zacks Investment ResearchGlanbia (GLAPY) Cut to Hold at Zacks Investment Research - January 4 at 12:14 AM
Can Germanys Political Crisis Stall EU Recovery? 5 PicksCan Germany's Political Crisis Stall EU Recovery? 5 Picks - November 23 at 5:58 AM
Glanbia Plc : A good buy now? Relative to peers, maybe.Glanbia Plc : A good buy now? Relative to peers, maybe. - November 16 at 2:44 PM

SEC Filings

Glanbia (OTCMKTS:GLAPY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Glanbia (OTCMKTS GLAPY) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.